StoneX Group Inc. Purchases Shares of 26,115 SPDR S&P Biotech ETF (NYSEARCA:XBI)

StoneX Group Inc. acquired a new position in SPDR S&P Biotech ETF (NYSEARCA:XBI) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 26,115 shares of the exchange traded fund’s stock, valued at approximately $2,352,000.

A number of other institutional investors also recently made changes to their positions in XBI. Tradewinds LLC. purchased a new stake in shares of SPDR S&P Biotech ETF during the fourth quarter worth about $509,000. Alliancebernstein L.P. bought a new position in SPDR S&P Biotech ETF during the 4th quarter valued at approximately $607,000. Edmond DE Rothschild Holding S.A. lifted its holdings in SPDR S&P Biotech ETF by 21.9% in the 4th quarter. Edmond DE Rothschild Holding S.A. now owns 3,288 shares of the exchange traded fund’s stock worth $296,000 after buying an additional 590 shares during the period. Wellington Management Group LLP grew its position in shares of SPDR S&P Biotech ETF by 24.1% in the 4th quarter. Wellington Management Group LLP now owns 65,250 shares of the exchange traded fund’s stock worth $5,876,000 after buying an additional 12,689 shares during the last quarter. Finally, O Shaughnessy Asset Management LLC increased its stake in shares of SPDR S&P Biotech ETF by 38.6% during the fourth quarter. O Shaughnessy Asset Management LLC now owns 718 shares of the exchange traded fund’s stock valued at $65,000 after buying an additional 200 shares during the period.

SPDR S&P Biotech ETF Trading Down 3.6 %

Shares of SPDR S&P Biotech ETF stock opened at $78.16 on Wednesday. The company’s fifty day simple moving average is $89.02 and its two-hundred day simple moving average is $93.62. SPDR S&P Biotech ETF has a 12-month low of $77.80 and a 12-month high of $105.47. The company has a market cap of $4.93 billion, a P/E ratio of 11.47 and a beta of 1.00.

SPDR S&P Biotech ETF Cuts Dividend

The firm also recently announced a dividend, which was paid on Wednesday, March 26th. Stockholders of record on Monday, March 24th were given a $0.0053 dividend. The ex-dividend date of this dividend was Monday, March 24th.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.